- Profile
- Personal Information
- Publications
Experts in Dermatology
Wei Huachen Wong Mun Loke Crystal Ugochi Aguh Mübeccel Akdis Donald V. Belsito Robert R. Walther Ellen A. Lumpkin Julian M. Mackay-Wiggan David M. Owens Angela Christiano Faramarz Samie Larisa J Geskin Chhanda Dutta Ashwini Rani SR Dr. Kushalappa P.A Dr. Veeranna S Dr. Jaydev B. Betkerur Dr. Kanthraj G.R. Dr. Ashwani P.K Dr. Ranugha P.S.S. View MoreIn addition to his role as Chairman of the Board of Alzheon, Dr. Garnier serves as Chairman of the Board of Directors for the Swiss biopharmaceutical company Idorsia, a spinout from Actelion. Dr. Garnier chaired Actelion leading its acquisition by Johnson & Johnson in 2017 for $30 billion. Dr. Garnier is a director of United Technologies Corporation and an Operating Partner at Advent International, a private equity firm. He is a member of the board of trustees of Newman’s Own Foundation and a trustee of The Max Planck Institute.
In addition to his role as Chairman of the Board of Alzheon, Dr. Garnier serves as Chairman of the Board of Directors for the Swiss biopharmaceutical company Idorsia, a spinout from Actelion. Dr. Garnier chaired Actelion leading its acquisition by Johnson & Johnson in 2017 for $30 billion. Dr. Garnier is a director of United Technologies Corporation and an Operating Partner at Advent International, a private equity firm. He is a member of the board of trustees of Newman’s Own Foundation and a trustee of The Max Planck Institute.